Lexpos News

MHRA Class 3 Medicines Recall: Flucloxacillin Capsules BP 500mg (Flamingo Pharma UK Ltd) Drug Alert Number: EL(26)A/32 Date issued: 30 June 2026 Flamingo Pharma UK Ltd have informed the MHRA that certain packs of Flucloxacillin Capsules BP 500mg contain the incorrect PIL. The affected packs contain the PIL for Amoxicillin 500mg Capsules instead of the PIL [...]

The post MHRA Class 3 Medicines Recall: Flucloxacillin Capsules BP 500mg (Flamingo Pharma UK Ltd) appeared first on Community Pharmacy England.

Update 07/07/2026: This Class 4 Medicines Defect Notification has been updated since its initial publication on 30 June 2026 to correct the expiry date for Gabapentin Relonchem 50 mg/ml Oral Solution, batch 21F1. Relonchem Limited has advised that the expiry date previously provided for batch 21F1 was incorrect. The correct expiry date is 01/04/2027. All [...]

The post MHRA Class 4 Medicines Defect Notification: Gabapentin Relonchem 50mg/ml Oral Solution (Relonchem Limited) appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (30/06/2026) confirmed the following list of price concessions for June 2026: Please note: Community Pharmacy England has submitted price concession applications for other medicines affected by pricing issues this month. We will issue further updates as soon as we hear back from the Department.  Drug Pack [...]

The post June 2026 Price Concessions 4th Update appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Benzylpenicillin benzathine 1.2 Million I.U. and 2.4 Million I.U. powder for suspension for injection (Brancaster Pharma Limited) Drug alert number: EL(26)A/30 Date issued: 29 June 2026 Brancaster Pharma Limited has informed the MHRA that the Patient Information Leaflet (PIL) in the cartons for the batches listed in this notification were [...]

The post MHRA Class 4 Medicines Defect Notification: Benzylpenicillin benzathine 1.2 Million I.U. and 2.4 Million I.U. powder for suspension for injection (Brancaster Pharma Limited) appeared first on Community Pharmacy England.

Pharmacy owners should soon receive confirmation from NHSBSA that the 2026/27 CPAF screening questionnaire will be available for completion from 1st July 2026 until 31st July 2026. As a result of NHS regulations introduced at the end of 2020, completion of CPAF is a requirement of the Terms of Service. Therefore, pharmacy owners must complete [...]

The post 2026/27 Community Pharmacy Assurance Framework (CPAF) screening questionnaire appeared first on Community Pharmacy England.